| MATERIALS AND METHODS

| Patients
The results of bacterial identification by MALDI-TOF/MS and standard urine culture were compared for urine samples from 142 suspected complicated UTI patients managed in Kobe University Hospital in 2015 and 2017, and 133 cases were culture positive. All 133 patients included in this study were diagnosed with complicated UTI by positive urine culture; that is, all the positive urine samples analyzed were consistent with complicated UTI. Complicated UTI was defined as UTI with an underlying disease affecting the urinary tract, such as stones, cancer or benign prostate hyperplasia, or systemic disease related to the immune system such as diabetes, steroid use or chemotherapy. 8 This study was approved by the Kobe University School of
Medicine institutional review board (IRB).
| Urine culture testing
Semiquantitative urine cultures were performed by procedures based on Cintron 16 recommendations using cystine lactose electrolyte deficient (CLED) agar (Nissui Pharmaceutical Co. Ltd., Tokyo, Japan). All bacterial concentrations were determined by a single technician and were expressed as the number of colony forming units (CFU) per milliliter. Samples were considered positive if they contained ≥10 5 or 10 4 to <10 5 CFU of urinary pathogens/mL of pure culture. The microorganisms isolated were identified by standard biochemical procedures. (xvi) Centrifugation at 15 000 g for 2 minutes.
| MALDI-TOF MS
After the last centrifugation, 1 μL of supernatant was applied to the MALDI target plate and air dried. After drying, the bacteria cul- According to the manufacturer's recommendations, a score ≥2.0 indicated species identification, a score between 1.7 and 2.0 indicated genus identification and a score of <1.7 indicated no identification. 10 Median scores for each isolated organism were obtained for comparison of accuracy.
| Statistical analyses
We determined significant differences using the χ 2 test or Fisher's exact test. Student's t test was used to compare the MALDI score between the two different methods. Differences were considered to be statistically significant at P<.05.
| RESULTS
| Urine culture
Conventional urine culture tests detected 133 bacterial cases from complicated UTI patients who were diagnosed by a single urologist (K.S.). We had four fungus isolations (3.0%), three Gram-positive rods (GPR) (2.3%), 40 Gram-positive cocci (GPC) (30.1%), and 86 Gramnegative rods (GNR) (64.7%). In detail, Escherichia coli was most often isolated (n=54, 40.6%) followed by Klebsiella pneumoniae (n=12, 9.0%),
Enterococcus faecalis (n=10, 7.5%), and Staphylococcus aureus (n=10, 7.5%) ( Table 1) . 
| MALDI-TOF MS
| Comparison between the 2 MALDI-TOF MS methods
Method 1 (n=53) resulted in the identification of E. coli (n=18, 34.0%),
K. pneumoniae (n=4, 7.5%) ( Table 2 ). Method 2 (n=59) results were E.
coli (n=28, 47.5%), E. faecalis (n=8, 13.6%) and K. pneumoniae (n=7, 11.9%) ( Table 3) . Dispersed cell aggregation after ultrasonication in Method 2 was confirmed under a microscope (data not shown). Method 2 significantly improved the total score (P=.009) and GPC score (P=.000) compared with Method 1.
| Correlation between cell number and MALDI score
To investigate the sensitivity of MALDI-TOF MS for UTI causative bacteria, we compared the results of colony count in culture and MALDI score in both sample preparation methods (Methods 1 and 2). As the results, MALDI-TOF MS which was prepared with Method 2 significantly detected UTI causative bacteria in species and genus level when bacterial count was more than 1×10 5 CFU/mL in the urine culture for GPC (Table 6 ). For GNR, Method 2 significantly improved the identification rate compared with Method 1 in genus level when bacterial count was more than 1×10 5 CFU/mL in the urine culture for GPC. When the bacterial count was less than 1×10 4 CFU/mL, Method 2 substantially improved the identification rate for both GPC and GNR, but the differences were not significant. sample) and time-consuming procedures. Also, the specific sequences or probes for detection and highly skilled personnel are required for accurate identification using these technically challenging methods.
| DISCUSSION
11
MALDI-TOF MS has been introduced in clinical laboratories as a novel bacterial identification method. This mass-spectrometry-based technology can directly and accurately identify bacteria within 15 minutes at moderate cost (<1 USD/sample), using only a small amount of a colony and a drop of matrix solution. 13 Also, MALDI-TOF MS is a highly automated procedure requiring ordinary practice skills. These advantages can allow clinical laboratories to rapidly provide accurate data to clinicians for UTI diagnosis in advance of the culture results.
We found high correspondence rates between conventional urine culture results from complicated UTI patients and routine standard MALDI-TOF MS in GNR, but not yeasts and some kinds of GPC. Some authors have reported that yeasts such as Candida spp. and some GPC could not be easily identified by MALDI-TOF MS at the species level, and required some modification in sample preparation methods such as protein extraction because of their thicker cell wall structure. 9 As as GNR (Tables 2 and 3) . Thus, our additional ultrasonication and centrifugation in sample preparation for MALDI-TOF MS could improve the performance for direct identification from urine samples.
We would like to emphasize the study limitations. First, our new method still has a nonidentification rate with GPC. We are now planning further revisions in method for a higher identification rate in GPC.
Second, the number of cases in this single center study is not large enough to draw definitive conclusions. Third, the study does not include data on the antimicrobial susceptibilities of the bacteria and cannot discriminate antibiotic resistant strains. For the establishment of a more accurate diagnostic tool, further studies need to be performed to improve protein extraction methods, systematically report MALDI-TOF MS results, and construct improved databases specially designed for the clinically significant pathogens. However, this study from 133 consecutive complicated UTI patient samples is closer to daily clinical situations and the results can be helpful to physicians caring for complicated UTI patients.
| CONCLUSIONS
Our modified method (Method 2) with additional ultrasonication and centrifugation in MALDI-TOF MS could directly identify causative bacteria (both GNR and GPC) in complicated UTI with higher correspondence rates than the conventional method (Method 1). Further modifications could offer higher rates of correspondence with cultures, resulting in a high-performance method of rapid and accurate bacterial identification that may possibly be substituted for culture eventually.
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